FDA Inspection 1304322 — BioTissue Holdings Inc

BioTissue Holdings Inc — FEI 3009809074

The FDA completed an inspection of BioTissue Holdings Inc on Feb 18, 2026 in Doral, FL. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 3 citations were issued during this inspection. Product area: Devices.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Feb 18, 2026
Fiscal Year
2026
Product Type
Devices
Project Area
Postmarket Assurance: Devices
Location
Doral, FL (United States)

Citations

IDCFRDescription
23213ISO 13485:2016 Clause 8.2.1Information gathered in feedback process not used as input into risk management
23255ISO 13485:2016 Clause 8.5.2Corrective action not taken
73121 CFR 803.50(a)(1)Report of Death or Serious Injury

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.